Application of cellular gene therapy for rheumatoid arthritis

References

• Panayi GS. T cell-dependent pathways in rheumatoid arthritis. Curr Opin Ftheumatol 1997;9:236–40.
   PubMedGoogle Scholar
• Hakoda M, Ishimoto T, Yamamoto K, Inoue K, Kamatani N, Miyasaka N, et al. Clonal analysis of T cell infiltrates in synovial tissue of patients with rheumatoid arthritis. Clin Immunol Immunopathol 1990;57:387–98.
   PubMedGoogle Scholar
• Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 2002;46:328–46.
   PubMed Web of Science ®Google Scholar
• Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleisdhmann RM, Weaver AL, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141–7.
   PubMed Web of Science ®Google Scholar
• Lipsky PE, van der Heijde DMFM, St. Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594–602.
   Google Scholar
• Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, et al. Treatment of rheumatoid arthritis with anakinra, a recombi-nant human interleukin-1 receptor antagonist, in combination with methotrexate. Arthritis Rheum 2002;46:614–24.
   PubMed Web of Science ®Google Scholar
• Breedveld FC, Weisman MC, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, et al. The PREMIER study. A multicenter, ramdomized, double-blind clinical trial of combination therapy with adalinumab plus methotrexate alone or adalinumab alone in patients with early, appressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006; 54:26–37.
   Google Scholar
• Liblau RS, Singer SM, McDevitt HO. Thl and Th2 CD4* T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16: 34–8.
   Google Scholar
• Epstein WV. Expectation bias in rheumatoid arthritis clinical tri-als. The anti-CD4 monoclonal antibody experience. Arthritis Rheum 1996;39:1773–80.
   PubMed Web of Science ®Google Scholar
• Plows D, Kontogeorgos G, Kollias G. Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen. J Immunol 1999;162:1018–23.
   Google Scholar
• Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? II. T cell-independent machanisms from beginning to end. Arthritis Rheum 2002;46:298–308.
   PubMed Web of Science ®Google Scholar
• Burger D, Dayer JM. Cytokines, acute-phase proteins, and hor-mones: IL-1 and TNF-alpha production in contact-mediated acti-vation of monocytes by T lymphocytes. Ann NY Acad Sci 2002;966:464–73.
   PubMed Web of Science ®Google Scholar
• Genovese MC, Becker JC, Schiff M, Luggen M, Sherrer Y, Kremer J, et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Engl J Med 2005;353:1114–23.
   PubMed Web of Science ®Google Scholar
• Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark sub-sets of T cells associated with certain inflammatory reactions. J Chin Invest 1998;101:746–54.
   PubMed Web of Science ®Google Scholar
• Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K. Selective accumulation of CCR5' T lymphocytes into inflamed joint of rheumatoid arthritis. Int Immunol 1999;11:553–9.
   PubMed Web of Science ®Google Scholar
• Robbins PD, Evans CH, Chernajovsky Y. Gene therapy for arthri-tis. Gene Ther 2003;10:902–11.
   Google Scholar
• Chernajovsky Y, Gould DJ, Podhajcer OL. Gene therapy for au-toimmune diseases: quo vadis? Nat Rev Immunol 2004;4:800–11.
   Google Scholar
• Shaw MK, Lorens JB, Dhawan A, DalCanto R, Tse HY, Tran AB, et al. Local delivery od interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomy-elitis. J Exp Med 1997;185:1711–4.
   PubMed Web of Science ®Google Scholar
• Mathisen PM, Yu M, Johnson JM, Drazba JA, Touhy VK. Treat-ment of experimental autoimmune encephalomyelitis with geneti-cally modified memory T cells. J Exp Med 1997;186:159–64.
   Google Scholar
• Nakajima A, Seroogy CM, Sandora MR, Tamer IH, Costa GL, Taylor-Edwards C, et al. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Chin Invest 2001;107:1293–301.
   Google Scholar
• Tamer IH, Nakajima A, Seroogy CM, Erman J, Levicnik A, Contag CH, et al. Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4. Clin Immunol 2002;105:304–14.
   PubMed Web of Science ®Google Scholar
• Smith R, Tamer IH, Hollenhorst M, Lin C, Levicnik AU, Fathman CG, et al. Localized expression of an anti-TNF single-chain anti-body prevents development of collagen-induced arthritis. Gene Ther 2003;10:1248–57.
   PubMed Web of Science ®Google Scholar
• Costa GL, Sandora M, Nakajima A, Nguyen E, Taylor-Edwards C, Slavin AJ, et al. Adoptive immunotherapy of experimental auto-immune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol 2001;167: 2379–87.
   Google Scholar
• Chen LZ, Hochwald GM, Dakin G, Cheng C, Simmons WJ, Dranoff G, et al. Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-bl. Proc Natl Acad Sci USA 1998;95:12516–21.
   PubMed Web of Science ®Google Scholar
• Setoguchi K, Misaki Y, Araki Y, Fujio K, Kawahata K, Kitamura T, et al. Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen. J Immunol 2000;165:5980–6.
   PubMed Web of Science ®Google Scholar
• Costa GL, Benson JM, Seroogy CM, Achacoso P, Fathman CG, Nolan GP. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J Immunol 2000;164:3581–90.
   PubMed Web of Science ®Google Scholar
• Evans CH, Ghivizzani SC, Oligino TA, Robbins PD. Future of adenoviruses in the gene therapy of arthritis. Arthritis Res 2001;3: 142–6.
   PubMedGoogle Scholar
• Kessels HW, Wolkers MC, van den Boom MD, van der Valk MA, Schumacher TN. Immunotherapy through TCR gene transfer. Nat Immunol 2001;2:957–61.
   Google Scholar
• Stanislawski T, Voss RH, Lotz C, Sadovnikova E, Willemsen RA, Kuball J, et al. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol 2001;2: 962–70.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Von Katie C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, et al. LM02-associated clonal T cell proliferation in two patients after gene therapy for SCID-Xi. Sci-ence 2003;302: 415–9.
   Google Scholar
• Slavin AJ, Tamer IH, Nakajima A, Urbanek-Ruiz I, McBride J, Contag CH, et al. Adoptive cellular gene therapy of autoimmune disease. Autoimmun Rev 2002;1:213–9.
   PubMedGoogle Scholar
• Tamer IH, Slavin AJ, McBride J, Levicnik A, Smith R, Nolan GP, et al. Treatment of autoimmune disease by adoptive cellular gene therapy. Ann NY Acad Sci 2003;998:512–9.
   PubMed Web of Science ®Google Scholar
• Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994;180:1961–6.
   PubMed Web of Science ®Google Scholar
• Nakajima A, Hirose S, Yagita H, Okumura K. Roles of IL-4 and IL-12 in the development of lupus in NZB/W Fl mice. J Immunol 1997;158:1466–72.
   PubMed Web of Science ®Google Scholar
• Chen Y, Kuchroo VK, Inobe J, Haller DA, Weiner HL. Regula-tory T cell clones induced by oral tolerance: suppression of autoim-mune encephalomyelitis. Science 1994;265:1237–40.
   Google Scholar
• Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits anti-gen-specific T-cell responses and prevents colitis. Nature 1997; 389:737–42.
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 2005;17:638–42.
   PubMed Web of Science ®Google Scholar
• Randolph DA, Fathman CG. Cd4(+)Cd25(+) regulatory T cells and their therapeutic potential. Annu Rev Med 2006;57:381–402.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:303–10.
   PubMed Web of Science ®Google Scholar
• Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimu-lation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3: 135–42.
   Google Scholar
• McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, et al. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311–23.
   PubMed Web of Science ®Google Scholar
• Lepault F, Gagnerault MC. Characterization of peripheral regula-tory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 2000;164:240–7.
   PubMed Web of Science ®Google Scholar
• Hon i S, Nomura T, Sakaguchi S. Control of regulatory T cell devel-opment by the transcription factor Foxp3. Science 2003;299: 1057–61.
   Google Scholar
• Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27:68–73.
   PubMed Web of Science ®Google Scholar
• Anandasabapathy N, Ford GS, Bloom D, Hotness C, Paragas V, Seroogy C, et al. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 2003;18:535-47. CH-reactive T cells and CH-induced arthritis. J Clin Invest 2003;112:1332-41. Contag PR, Olomu IN, Stevenson DK, Contag CH. Biolumines-cent indicator in living mammals. Nat Med.1998; 4,245-7. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003;9:1144-50. Hardy J, Edinger M, Bachmann MH, Negrin RS, Fathman CG, Contag CH. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol 2001;29:1353-60. Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R, Bahnson AB, et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996;20:1261-80. Jorgensen C, Noel D, Apparailly F, Sany J. Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and bone: the next challenge in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 2001;60: 305–9.
   Google Scholar
• Ermann J, Szanya V, Ford GS, Paragas V, Fathman CG, Lejon K. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy. J Immunol 2001;167:4271-5.53.
   Web of Science ®Google Scholar
• Lechman ER, Keravala A, Nash J, Kim SH, Mi Z, Robbins PD. The contralateral effect conferred by intra-articular adenovirus- 54. mediated gene transfer of viral IL-10 is specific to the immunizing antigen. Gene Ther 2003;10:2029–35.
   Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.55.
   Google Scholar
• Min W-P, Gorczynski R, Huang X-Y, Kushida M, Kim P, Obataki M, et al. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong al- 56. lograft survival. J Immunol 2000;164: 161–7.
   Google Scholar
• Kim HS, Kim S, Evans CH, Ghivizzani SC, Oligino T, Robbins PD. Effective treatment of established murine collagen-induced arthri-tis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol 2001;166:3499-505.57.
   Google Scholar
• Morita Y, Yang J, Gupta R, Shimizu K, Shelden EA, Endres J, et al. Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest 2001;107:1275–84.
   PubMed Web of Science ®Google Scholar
• Liu Z, Xu X, Hsu H-C, Tousson A, Yang P-A, Wu Q, et al. CII-DC-AdTFtAIL cell gene therapy inhibits infiltration of
   Google Scholar